<?xml version="1.0"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?>
  <?DTDIdentifier.IdentifierType public?>
  <?SourceDTD.DTDName journalpublishing.dtd?>
  <?SourceDTD.Version 2.3?>
  <?ConverterInfo.XSLTName jp2nlmx2.xsl?>
  <?ConverterInfo.Version 2?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Interdiscip Toxicol</journal-id>
      <journal-id journal-id-type="publisher-id">ITX</journal-id>
      <journal-title-group>
        <journal-title>Interdisciplinary Toxicology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1337-6853</issn>
      <issn pub-type="epub">1337-9569</issn>
      <publisher>
        <publisher-name>Slovak Toxicology Society SETOX</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmc">3090056</article-id>
      <article-id pub-id-type="pmid">21577286</article-id>
      <article-id pub-id-type="publisher-id">ITX-4-056</article-id>
      <article-id pub-id-type="doi">10.2478/v10102-011-0011-0</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>The new pyridoindole antioxidant SMe1EC2 and its intervention in hypoxia/hypoglycemia-induced impairment of longterm potentiation in rat hippocampus</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>G&#xE1;sp&#xE1;rov&#xE1;</surname>
            <given-names>Zdenka</given-names>
          </name>
          <xref ref-type="aff" rid="AF0001">1</xref>
          <xref ref-type="corresp" rid="cor1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>&#x160;nirc</surname>
            <given-names>Vladim&#xED;r</given-names>
          </name>
          <xref ref-type="aff" rid="AF0001">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>&#x160;tolc</surname>
            <given-names>Svorad</given-names>
          </name>
          <xref ref-type="aff" rid="AF0001">1</xref>
          <xref ref-type="aff" rid="AF0002">2</xref>
        </contrib>
      </contrib-group>
      <aff id="AF0001"><label>1</label>Institute of Experimental Pharmacology &amp; Toxicology, Slovak Academy of Sciences, SK-84104 Bratislava, Slovak Republic</aff>
      <aff id="AF0002"><label>2</label>BIONT, Inc., Bratislava, Slovak Republic</aff>
      <author-notes>
        <corresp id="cor1"><italic>Correspondence address</italic>: <bold>Zdenka G&#xE1;sp&#xE1;rov&#xE1; PhD.</bold> Institute of Experimental Pharmacology &amp; Toxicology, Slovak Academy of Sciences D&#xFA;bravsk&#xE1; cesta 9, 841 04 Bratislava, Slovak Republic. TEL.: +421-2-59410654 &#xB7; E-MAIL: <email xlink:href="zdenka.gasparova@savba.sk">zdenka.gasparova@savba.sk</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>3</month>
        <year>2011</year>
      </pub-date>
      <pub-date pub-type="epub">
        <month>3</month>
        <year>2011</year>
      </pub-date>
      <volume>4</volume>
      <issue>1</issue>
      <fpage>56</fpage>
      <lpage>61</lpage>
      <history>
        <date date-type="received">
          <day>21</day>
          <month>2</month>
          <year>2011</year>
        </date>
        <date date-type="rev-recd">
          <day>14</day>
          <month>3</month>
          <year>2011</year>
        </date>
        <date date-type="accepted">
          <day>18</day>
          <month>3</month>
          <year>2011</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2011 Slovak Toxicology Society SETOX</copyright-statement>
        <copyright-year>2011</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0/">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Previously, the pyridoindole SMe1EC2 was proved to inhibit lipoperoxidation and carbonylation of proteins in rat brain cortex in the system Fe<sup>2+</sup>/ascorbate and improvement of resistance of the rat hippocampus was reported against ischemic conditions <italic>in vitro</italic> (hypoxia/hypoglycemia) expressed by the enhanced neuronal response recovery in reoxygenation. The hippocampus fulfils many of the criteria for a neuronal correlate of learning and memory. Recently, an impairment of hippocampal long-term potentiation (LTP) was reported under oxidative stress. Different therapies, including antioxidants, have been studied intensively concerning the impairment of neuronal plasticity. In this study marked reduction of LTP, elicited by a single burst (100 Hz, 1s) in the CA3-CA1 area of rat hippocampal slices, was shown due to transient hypoxia/hypoglycemia compared to control slices. On the basis of previously reported antioxidant and neuroprotective effects of SMe1EC2, its effect on loss of LTP in the hippocampus due to ischemic conditions was studied <italic>in vitro</italic>. The pyridoindole tested improved hypoxia/hypoglycemia-induced reduction of LTP compared to untreated hypoxic slices. An opposite effect of SMe1EC2 on LTP induction was found in control slices. The mechanism of SMe1EC2 action on LTP in ischemic conditions has been suggested to differ from the mechanism of its effect in &#x201C;normoxia&#x201D; and may be due to different redox status in control and ischemic brain tissue. The manifested LTP-protective effect of SMe1EC2 observed in the rat hippocampus exposed to ischemia <italic>in vitro</italic> may find exploitation in therapy associated with injured neuronal plasticity in some conditions, including ischemia, trauma and aging in man.</p>
      </abstract>
      <kwd-group>
        <kwd>oxidative stress</kwd>
        <kwd>hippocampus</kwd>
        <kwd>long-term potentiation</kwd>
        <kwd>pyridoindole</kwd>
        <kwd>rat</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro" id="S0001">
      <title>Introduction</title>
      <p>Recently it has been generally accepted that oxidative stress is one of the multiple mechanisms participating in brain damage and it has been implicated in the pathogenesis of chronic neurodegenerative disorders like Alzheimer and Parkinson diseases (Keller <italic>et al</italic>., <xref ref-type="bibr" rid="CIT0015">2005</xref>; Mariani <italic>et al</italic>., <xref ref-type="bibr" rid="CIT0018">2005</xref>; Moreira <italic>et al</italic>., <xref ref-type="bibr" rid="CIT0020">2006</xref>) and in acute brain injuries such as ischemia or head trauma (Sopala <italic>et al</italic>., <xref ref-type="bibr" rid="CIT0026">2000</xref>; Dai <italic>et al</italic>., <xref ref-type="bibr" rid="CIT0003">2007</xref>; Tariq <italic>el al</italic>., <xref ref-type="bibr" rid="CIT0030">2010</xref>). Oxidative stress is believed to be one of the aspects contributing to a decline in function of the central nervous system during acute and chronic neuronal damage and aging. Traumatic brain injury produces learning and memory deficits that are thought to be mediated partially by impaired hippocampal function. Long-term potentiation (LTP), a long-lasting increase in synaptic strength of monosynaptic pathways in the hippocampus, makes it an attractive model to study cellular mechanisms that may participate in learning and memory formation.</p>
      <p>Neuronal tissue is equipped with protective enzymatic and non-enzymatic defensive anti-oxidative mechanisms which offer a partial resistance to oxidative stress. Disturbance of the balance between the production of reactive oxygen species and the capacity of protective antioxidants produces neuronal damage. The idea of neuroprotective therapy for acute ischemic stroke is based on results from extensive studies on animal models of brain ischemia, demonstrating efficacy of many natural and synthetic agents. Therapy using antioxidants is intensively studied. Contrary to positive conclusions with antioxidants from experimental animal models, clinical experience failed to find neuroprotectants efficient in human stroke, infarction, brain trauma, tissue preservation, etc. Novel approaches and carefully designed trials are needed to disclose more potent drugs with neuroprotective and recovery enhancing effects (Fisher, <xref ref-type="bibr" rid="CIT0005">2011</xref>).</p>
      <p>In the Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Slovakia, the bearing issue is focused on the search for new compounds with antioxidant and antiradical properties. This research was based on stobadine, the compound revealing remarkable antioxidant, radical scavenging, and tissue protective action (Hor&#xE1;kov&#xE1; and &#x160;tolc, <xref ref-type="bibr" rid="CIT0006">1998</xref>). Sites in the pyridoindole stobadine molecule responsible for antioxidant and antiradical properties were identified and new derivatives have been prepared by an appropriate substitution (&#x160;tolc <italic>et al</italic>., <xref ref-type="bibr" rid="CIT0028">2008</xref>); some results have been included in the Slovak patent No. 287506 (&#x160;tolc <italic>et al</italic>., <xref ref-type="bibr" rid="CIT0029">2010</xref>). One of the new derivatives is the compound 2-ethoxycarbonyl-8-methoxy-2,3,4,4a,5,9b-hexahydro-1<italic>H</italic>-pyrido-[4,3b]indolinium chloride, code SMe1EC2, substituted with methoxy-group on the aromatic cycle and ethoxycarbonyl-group substituted in position 2- of the piperidine nitrogen. The pyridoindole SMe1EC2 was found to have higher antioxidant capability than the parent drug stobadine, at simultaneous elimination of the alpha<sub>1</sub>-adrenolytic activity considered as undesired side effect and it displayed a markedly decreased acute toxicity compared to stobadine after <italic>p.o., i.p.</italic> and <italic>i.v.</italic> administration to mice (<xref ref-type="table" rid="T0001">Table 1</xref>). Beneficial effects of this prospective pyridoindole have been established (&#x160;tolc <italic>et al</italic>., <xref ref-type="bibr" rid="CIT0028">2008</xref>) and they are briefly summarized in <xref ref-type="table" rid="T0002">Table 2</xref>. This compound revealed remarkably higher inhibitory effect on lipoperoxidation in rat brain homogenates in the presence of Fe<sup>2+</sup>/ascorbate system than did stobadine. Similarly, the inhibitory effect of SMe1EC2 on oxidative impairment of creatine phosphokinase in rat brain homogenate exposed to Fe<sup>2+</sup>/ascorbate system was of higher potency than that of stobadine. The neuroprotective action of the pyridoindole SMe1EC2 was found also in the model of acute head trauma in mice where diminished sensomotoric impairment (expressed as &#x201C;time on wire&#x201D;), eliminated the increase in brain wet weight, which could be ascribed to acute brain edema. Along with this, the incidence of subdural bleeding, brain parenchyma bleeding, and bleeding into brain chambers were significantly reduced in treated mice. Administration of SMe1EC2 fully prevented a decrease in brain total glutathione level elicited by trauma. Recently SMe1EC2 was found to inhibit formation of protein carbonyl groups induced by the Fe<sup>2+</sup>/ascorbate system in brain cortex homogenates of rats (G&#xE1;sp&#xE1;rov&#xE1; <italic>et al</italic>., <xref ref-type="bibr" rid="CIT0009">2010a</xref>). The improvement of neuronal function recovery in reoxygenation after transient exposure to hypoxia/hypoglycemia of rat hippocampal slices was observed in several studies regardless the way of its administration (G&#xE1;sp&#xE1;rov&#xE1; <italic>et al</italic>., <xref ref-type="bibr" rid="CIT0007">2008</xref>; <xref ref-type="bibr" rid="CIT0008">2009</xref>; G&#xE1;sp&#xE1;rov&#xE1; <italic>et al</italic>., G&#xE1;sp&#xE1;rov&#xE1; <italic>et al</italic>., <xref ref-type="bibr" rid="CIT0010">2010b</xref>). The new pyridoindole has been suggested to apply its neuroprotective action in different events connected to oxidative injury. In this study, we examined its action in impairment of neuronal plasticity due to exposure to transient hypoxia/hypoglycemia in the rat hippocampus, a brain region particularly vulnerable to oxidative stress, yet also exceptionally plastic.</p>
      <table-wrap id="T0001" position="float">
        <label>Table 1</label>
        <caption>
          <p>Comparison of SMe1EC2 and stobadine.</p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <th align="left" rowspan="1" colspan="1">Action</th>
              <th align="center" rowspan="1" colspan="1">SMe1EC2</th>
              <th align="center" rowspan="1" colspan="1">Stobadine</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left" rowspan="1" colspan="1"><bold>Anti-lipoperoxidation effect</bold> (rat brain homogenate)</td>
              <td align="left" rowspan="1" colspan="1">pIC<sub>50</sub>=5.487&#xB1;0.014</td>
              <td align="left" rowspan="1" colspan="1">pIC<sub>50</sub>=4.469&#xB1;0.023</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1"><bold>Inhibition of creatine phosphokinase oxidative impairment</bold> (rat brain homogenate)</td>
              <td align="left" rowspan="1" colspan="1">2.284</td>
              <td align="left" rowspan="1" colspan="1">1 (equivalent activity)</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1"><bold>Alpha-adrenolytic effect</bold> (rat aortic rings)</td>
              <td align="left" rowspan="1" colspan="1">no effect</td>
              <td align="left" rowspan="1" colspan="1">pA<sub>2</sub>=7.26&#xB1;0.12</td>
            </tr>
            <tr>
              <td align="left" rowspan="3" valign="middle" colspan="1"><bold>Acute toxicity</bold> (mouse)</td>
              <td align="left" rowspan="1" colspan="1">LD<sub>50</sub>&gt;2400 mg/kg, <italic>p.o</italic>.</td>
              <td align="left" rowspan="1" colspan="1">LD<sub>50</sub>=323.68 mg/kg, <italic>p.o</italic>.</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">LD<sub>50</sub>=1963.36 mg/kg, <italic>i.p</italic>.</td>
              <td align="left" rowspan="1" colspan="1">LD<sub>50</sub>=164.44 mg/kg, <italic>i.p</italic></td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">LD<sub>50</sub>=181.13 mg/kg, <italic>i.v.</italic>.</td>
              <td align="left" rowspan="1" colspan="1">LD<sub>50</sub>=63.13 mg/kg, <italic>i.v</italic>.</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <table-wrap id="T0002" position="float">
        <label>Table 2</label>
        <caption>
          <p>Neuroprotective and antioxidant action of SMe1EC2.</p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <th align="left" rowspan="1" colspan="1">Model of injury</th>
              <th align="left" rowspan="1" colspan="1">Effect of SMe1EC2</th>
              <th align="left" rowspan="1" colspan="1">Animal/Tissue</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left" rowspan="1" colspan="1">
                <bold>Fe</bold>
                <sup>
                  <bold>2+</bold>
                </sup>
                <bold>/ascorbate</bold>
              </td>
              <td align="left" rowspan="1" colspan="1">Inhibitory effect on lipoperoxidation</td>
              <td align="left" rowspan="1" colspan="1">rat/brain homogenate</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">
                <bold>Fe</bold>
                <sup>
                  <bold>2+</bold>
                </sup>
                <bold>/ascorbate</bold>
              </td>
              <td align="left" rowspan="1" colspan="1">Inhibitory effect on oxidation of creatine phosphokinase</td>
              <td align="left" rowspan="1" colspan="1">rat/brain homogenate</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">
                <bold>Fe</bold>
                <sup>
                  <bold>2+</bold>
                </sup>
                <bold>/ascorbate</bold>
              </td>
              <td align="left" rowspan="1" colspan="1">Inhibitory effect on formation of protein carbonyl groups</td>
              <td align="left" rowspan="1" colspan="1">rat/brain cortex homogenate</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">
                <bold>Acute head trauma</bold>
              </td>
              <td align="left" rowspan="1" colspan="1">Improvement of sensomotoric stage</td>
              <td align="left" rowspan="1" colspan="1">mouse</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">
                <bold>Acute head trauma</bold>
              </td>
              <td align="left" rowspan="1" colspan="1">Reduction in brain edema</td>
              <td align="left" rowspan="1" colspan="1">mouse/brain</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">
                <bold>Acute head trauma</bold>
              </td>
              <td align="left" rowspan="1" colspan="1">Reduction of bleeding into brain</td>
              <td align="left" rowspan="1" colspan="1">mouse/brain</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">
                <bold>Acute head trauma</bold>
              </td>
              <td align="left" rowspan="1" colspan="1">Prevention of injury-induced decrease in total glutathione level</td>
              <td align="left" rowspan="1" colspan="1">mouse/brain homogenate</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">
                <bold>Acute head trauma</bold>
              </td>
              <td align="left" rowspan="1" colspan="1">Elimination of injury-induced increase in total lactate level</td>
              <td align="left" rowspan="1" colspan="1">mouse/brain homogenates</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">
                <bold>Hypoxia/hypoglycemia</bold>
              </td>
              <td align="left" rowspan="1" colspan="1">Improved recovery of neuronal response in reoxygenation</td>
              <td align="left" rowspan="1" colspan="1">rat/hippocampal slices</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">
                <bold>Hypoxia/hypoglycemia</bold>
              </td>
              <td align="left" rowspan="1" colspan="1">Reduction of edema</td>
              <td align="left" rowspan="1" colspan="1">rat/hippocampal slices</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
    </sec>
    <sec sec-type="methods" id="S0002">
      <title>Methods</title>
      <sec id="S20003">
        <title>Animals</title>
        <p>Male Wistar rats, 2 months old, weight 221&#xB1;11 g, n=40, from the breeding station Dobr&#xE1; Voda (Slovak Republic, reg. No. SK CH 4004) were used. The rats had free access to water and food pellets and were kept on 12/12 h light/dark cycle. Animals were acclimated one week prior to the experiments. All procedures involving animals were performed in compliance with the Principles of Laboratory Animal Care issued by the Ethical Committee of the Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences and by the State Veterinary and Food Administration of Slovakia.</p>
      </sec>
      <sec id="S20004">
        <title>Drug</title>
        <p>The pyridoindole derivative SMe1EC2 was synthetized in the Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Slovakia.</p>
      </sec>
      <sec id="S20005">
        <title>Rat hippocampal slices preparation and LTP induction</title>
        <p>The rats were briefly anesthetized by ether, decapitated and the hippocampus was quickly removed from the brain and cut into 400 &#xB5;m thick slices with the McIllwain Tissue Chopper. The slices were kept in the holding chamber for at least 1-h recovery period before the experiment started. During the experiments, the slice was kept in the recording chamber and continuously perfused with artificial cerebrospinal fluid (ACSF) bubbled with 95% O<sub>2</sub> and 5% CO<sub>2</sub> at the constant rate monitored by aquatic manometer. Oxygen/glucose deprivation was obtained by replacing the gas mixture with O<sub>2</sub> by the gas mixture with N<sub>2</sub> by switching the valves, along with superfusion of the slices with ACSF equilibrated with the oxygen-free gas mixture and diminished glucose from 10 to 4&#xD7;10<sup>&#x2212;3</sup> mol/l. The temperature of the recording chamber was kept at 35.0&#x2013;35.5&#xB0;C. Neurons were stimulated via Schaffer collaterals in the CA3 region and field excitatory postsynaptic potentials (fEPSPs) were recorded extracellularly from the pyramidal cell layer in the CA1 region. To measure baseline synaptic transmission, the stimuli were applied every 20 s. The stimulus intensity was reduced to 50% or less of the fEPSP amplitude when a population spike generation started to be detected. The slices were stabilized for about 15 min, the drug tested was applied during 30 min before high-frequency stimulation (HFS) in &#x201C;normoxic&#x201D; slices, or 30 min before transient hypoxia/hypoglycemia in hypoxic slices, and then during the whole experiment. Hypoxic slices were exposed to short 3.5 min hypoxia/hypoglycemia followed by 20 min reoxygenation. LTP was induced by a single 100-Hz train with 1000ms train duration. After HFS, the baseline stimulation recording continued for at least 60 min.</p>
      </sec>
      <sec id="S20006">
        <title>Statistical analysis</title>
        <p>The electrophysiological measurements were done from 6&#x2013;10 rats in each experimental group. Three stimuli per minute were averaged in off-line analysis. The normalized value 1 represents the mean fEPSP amplitude recorded during a 10-min period before HFS in each slice. In the figures, each value represents the mean fEPSP amplitude (&#xB1; SEM) at a given time from 6&#x2013;13 hippocampal slices. The mean values for the last 10 min (50&#x2013;60 min after HFS) for each group were calculated and compared. Statistical significance of differences between these values was established by Student&#x2032;s t-test and <italic>p-</italic>values below 0.05 were considered statistically significant.</p>
      </sec>
    </sec>
    <sec sec-type="results" id="S0007">
      <title>Results</title>
      <sec id="S20008">
        <title>Effect of SMe1EC2 and LTP-induction in control and hypoxic rat hippocampal slices</title>
        <p>LTP was elicited by a single burst (100 Hz, 1 s) with the magnitude 186.0&#xB1;15.8% measured within the last 50&#x2013;60 min after HFS in the control (&#x201C;normoxic&#x201D;) rat hippocampal slices, compared to the mean baseline fEPSP amplitude measured during 10 min before HFS. In the slices exposed to 3.5-min hypoxia/hypoglycemia, transient impairment or complete cessation of synaptic transmission during hypoxia was observed with almost complete recovery in 20-min reoxygenation (not shown). This short exposure of slices to hypoxia/hypoglycemia resulted in marked impairment of LTP (<xref ref-type="fig" rid="F0001">Figure 1</xref>). Immediately after HFS, the increase of fEPSP response due to HFS was smaller compared to that in control slices, as well as to that during further 60 min of measurement. The mean fEPSP amplitude within 50&#x2013;60 min after HFS was similar to that before HFS in hypoxic slices.</p>
        <fig id="F0001" position="float">
          <label>Figure 1</label>
          <caption>
            <p>LTP induced by a single burst (100 Hz, 1s) in CA3-CA1 pathway of control rat hippocampal slices (n=13) compared to the same response in slices (n=10) exposed to 3.5-min hypoxia/hypoglycemia and after 20 min to high-frequency stimulation. Arrow shows the application of HFS. Values express mean&#xB1;SEM.</p>
          </caption>
          <graphic xlink:href="ITX-4-056-g001"/>
        </fig>
        <p>The effect of SMe1EC2 on LTP induction in hypoxic slices is shown in <xref ref-type="fig" rid="F0002">Figure 2</xref>. In the concentration of 3&#xD7;10<sup>&#x2212;6</sup> mol/l a significant improvement in induction of LTP was observed in hypoxic slices treated by SMe1EC2 compared to the response in hypoxic untreated slices. Both low concentrations of SMe1EC2 tested failed to affect the impairment of LTP in the hippocampus after experimental ischemia <italic>in vitro</italic>.</p>
        <fig id="F0002" position="float">
          <label>Figure 2</label>
          <caption>
            <p>LTP induced by a single burst (100 Hz, 1s) in CA3-CA1 pathway of slices (n=10) exposed to 3.5-min hypoxia/hypoglycemia and after 20 min to high-frequency stimulation compared with LTP in hypoxic slices treated 30 min before hypoxia/hypoglycemia and during whole experiment by the pyridoindole SMe1EC2 (1&#xD7;10<sup>&#x2212;7</sup>; 1&#xD7;10<sup>&#x2212;6</sup>; 3&#xD7;10<sup>&#x2212;6</sup> mol/l; n=9; n=8; n=8, respectively). Arrow shows the application of HFS. Values represent mean&#xB1;SEM.</p>
          </caption>
          <graphic xlink:href="ITX-4-056-g002"/>
        </fig>
        <p>The compound SMe1EC2 (1&#xD7;10<sup>&#x2212;7</sup>; 1&#xD7;10<sup>&#x2212;6</sup> mol/l), present 30 min before HFS, appears to reduce LTP magnitude in &#x201C;normoxic&#x201D; slices 50&#x2013;60 min after HFS and this reduction was significant in the highest concentration tested (3&#xD7;10<sup>&#x2212;6</sup> mol/l, <italic>p=</italic>0.0187). The mean fEPSP amplitudes measured during 50&#x2013;60 min after HFS are summarized in <xref ref-type="fig" rid="F0003">Figure 3</xref>.</p>
        <fig id="F0003" position="float">
          <label>Figure 3</label>
          <caption>
            <p>Normalized fEPSP amplitude measured in 50&#x2013;60 min after HFS in control slices (C), control slices treated with SMe1EC2, hypoxic untreated slices (H) and hypoxic slices treated with SMe1EC1 in concentration of 1&#xD7;10<sup>&#x2212;7</sup>; 1&#xD7;10<sup>&#x2212;6</sup> and 3&#xD7;10<sup>&#x2212;6</sup> mol/l. Significant difference between fEPSP amplitude in control slices compared to hypoxic slices (<sup>###</sup><italic>p=</italic>0.0001), between controls and control slices treated with SMe1EC2 (3&#xD7;10<sup>&#x2212;6</sup> mol/l) (**<italic>p</italic>=0.0187), and between hypoxic slices compared to hypoxic slices treated with SMe1EC2 (3&#xD7;10<sup>&#x2212;6</sup> mol/l) (<sup>++</sup>
<italic>p=</italic>0.0058). Significant difference was calculated by Student t-test.</p>
          </caption>
          <graphic xlink:href="ITX-4-056-g003"/>
        </fig>
      </sec>
    </sec>
    <sec sec-type="discussion" id="S0009">
      <title>Discussion</title>
      <p>Loss of LTP in the hippocampus was observed in traumatic brain injury (Miyazaki <italic>et al</italic>., <xref ref-type="bibr" rid="CIT0019">1992</xref>; Reeves <italic>et al</italic>., <xref ref-type="bibr" rid="CIT0022">1995</xref>; Sick <italic>et al</italic>., <xref ref-type="bibr" rid="CIT0025">1998</xref>; Sanders <italic>et al</italic>., <xref ref-type="bibr" rid="CIT0023">2000</xref>; Schwarzbach <italic>et al</italic>., <xref ref-type="bibr" rid="CIT0024">2006</xref>), after experimental subarachnoid hemorrhage (Tariq <italic>et al</italic>., <xref ref-type="bibr" rid="CIT0030">2010</xref>), after ischemia (Ito <italic>et al</italic>., <xref ref-type="bibr" rid="CIT0004">1994</xref>; Sopala <italic>et al</italic>., <xref ref-type="bibr" rid="CIT0026">2000</xref>; Dai <italic>et al</italic>., <xref ref-type="bibr" rid="CIT0003">2007</xref>) and after hypoxia/hypoglycemia (G&#xE1;sp&#xE1;rov&#xE1; <italic>et al</italic>., <xref ref-type="bibr" rid="CIT0007">2008</xref>). In human CNS tissue and rodent brain similar molecular mechanisms of LTP were reported (Cooke &amp; Bliss, <xref ref-type="bibr" rid="CIT0002">2006</xref>).</p>
      <p>The results presented in this article show that transient 3.5-min hypoxia/hypoglycemia of rat hippocampal slices resulted in significant reduction of LTP. These results are in good agreement with the observation that extracellular acidosis, which is associated with several pathological conditions in the CNS (like ischemia, hypoxia and neuronal injury), suppresses LTP induction (Vel&#xED;sek, <xref ref-type="bibr" rid="CIT0031">1998</xref>). An impairment of hippocampal LTP was also found in model oxidative stress induced by hydrogen peroxide in rats (Maalouf &amp; Rho, <xref ref-type="bibr" rid="CIT0017">2008</xref>).</p>
      <p>Neuroprotection from ischemic brain damage by diets was examined in animal models and in humans. Nutritional intervention due to antioxidants and polyphenolic compounds from fruits, vegetables, nuts and grains decreases markers of oxidative damage, such as malondialdehyde and protein carbonyls, and decreases levels of proinflammatory cytokines either directly or indirectly by reducing oxidative damage (Gemma <italic>et al</italic>., <xref ref-type="bibr" rid="CIT0012">2007</xref>). Vitamin E has been shown to improve age-related impairment in LTP (Murray &amp; Lynch, <xref ref-type="bibr" rid="CIT0021">1998</xref>), its administration improved the learning and memory ability of mouse offspring whose mothers were exposed to tabacco smoke during pregnancy (Yang <italic>et al</italic>., <xref ref-type="bibr" rid="CIT0032">2008</xref>) and improved cognitive behaviors (Joseph <italic>et al</italic>., <xref ref-type="bibr" rid="CIT0013">1999</xref>; Joseph <italic>et al</italic>., <xref ref-type="bibr" rid="CIT0014">1998</xref>). The effect of other antioxidants on LTP-impairment was tested in several studies. Oxidative impairment of hippocampal LTP induced by H<sub>2</sub>O<sub>2</sub> was prevented by ketone bodies (Maalouf &amp; Rho, <xref ref-type="bibr" rid="CIT0017">2008</xref>), which exert antioxidant effect in experimental model of neurological diseases. Similarly, the compound U-92032U-92032a Ca<sup>2+</sup> channel blocker and antioxidant, preserved LTP in hippocampal CA1 neurons when administered to gerbils 1 h prior to bilateral carotid artery occlusion (Ito <italic>et al</italic>., <xref ref-type="bibr" rid="CIT0004">1994</xref>).</p>
      <p>Thus there are several implications about putative neuroprotective action of antioxidants in loss of LTP due to oxidative stress. We focused on the effect of the compound SMe1EC2, the new pyridoindole derivative with antioxidant properties. Previously, the neuroprotective action of SMe1EC2 expressed by improved recovery of neuronal transmission in reoxygenation was found in rat hippocampal slices exposed to model ischemic conditions <italic>in vitro</italic>. Such an improvement of functional recovery was observed after transient hypoxia/hypoglycemia in different experiments where SMe1EC2 was: (1) applied into superfusing medium (3&#xD7;10<sup>&#x2212;8</sup>&#x2013;3&#xD7;10<sup>&#x2212;6</sup> mol/l); (2) after 10-day oral treatment of adult rats (50 and 250 mg/kg/day, <italic>p.o</italic>.), and (3) in offspring after 18-day treatment of the mothers (50 and 250 mg/kg/day, <italic>p.o</italic>.) (G&#xE1;sp&#xE1;rov&#xE1; <italic>et al</italic>., <xref ref-type="bibr" rid="CIT0007">2008</xref>; <xref ref-type="bibr" rid="CIT0008">2009</xref>; <xref ref-type="bibr" rid="CIT0010">2010b</xref>). The present data showed improved LTP due to SMe1EC2 treatment in hypoxic rat hippocampal slices and reduction of LTP in &#x201C;normoxic&#x201D; slices. Similar results were found with melatonin, which impaired LTP in the dentate gyrus area of the hippocampus and induced learning and memory deficit in control rats (Cao <italic>et al</italic>., <xref ref-type="bibr" rid="CIT0001">2009</xref>). Accordingly, administration of alpha-lipoic acid to control animals resulted in a significant impairment of LTP amplitude (Wang <italic>et al</italic>., <xref ref-type="bibr" rid="CIT0033">2008</xref>). The differential effect of antioxidants on LTP in control and hypoxic hippocampal slices may be due to the different redox status in control and ischemic brain tissue. The neuroprotective effect of SMe1EC2 during hypoxia/hypoglycemia may be explained by its high anti-lipoperoxidation activity, which presumably contributes to the preservation of the neuronal cell membrane and to its permeability, and further by its inhibitory effect on carbonylation of proteins mediated by conditions involving oxidative stress, and thus SMe1EC2 might protect neurons from damage of membrane lipids and protein receptors. The beneficial effect of SMe1EC2 on improved LTP in treated hypoxic hippocampal slices probably does not act by direct interaction with glutamate receptor. This assumption is based on results with its parent drug stobadine, which did not compete [<sup>3</sup>H]glutamate binding in rat brain membranes (Kvalt&#xED;nov&#xE1; &amp; &#x160;tolc <xref ref-type="bibr" rid="CIT0016">1997</xref>; G&#xE1;sp&#xE1;rov&#xE1;-Kvalt&#xED;nov&#xE1; &amp; &#x160;tolc, <xref ref-type="bibr" rid="CIT0011">2003</xref>).</p>
    </sec>
    <sec sec-type="conclusions" id="S0010">
      <title>Conclusion</title>
      <p>We conclude that the LTP-protective effect of SMe1EC2 found in the rat hippocampus exposed to model ischemia may prove beneficial in therapeutic application when neuronal plasticity is injured in some conditions including ischemia, trauma and aging in man. The mechanism of pyridoindole antioxidant effect in ischemic conditions may differ from the mechanism of its effect in control &#x201C;normoxic&#x201D; conditions.</p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Acknowledgement</title>
      <p content-type="acknowledgment">This study was supported by the grant VEGA 2/0048/11, Slovakia. The authors thank to Mrs. J&#xFA;lia Pol&#xE1;kov&#xE1; for her technical assistance.</p>
    </ack>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="CIT0001">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cao</surname>
              <given-names>XJ</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>WH</given-names>
            </name>
            <name>
              <surname>Zhu</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>She</surname>
              <given-names>JQ</given-names>
            </name>
            <name>
              <surname>Ruan</surname>
              <given-names>DY</given-names>
            </name>
          </person-group>
          <article-title>Effects of chronic administration of melatonin on spatial learning ability and long-term potentiation in lead-exposed and control rats</article-title>
          <source>Biomed Environ Sci</source>
          <year>2009</year>
          <volume>22</volume>
          <fpage>70</fpage>
          <lpage>75</lpage>
          <pub-id pub-id-type="pmid">19462691</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0002">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cooke</surname>
              <given-names>SF</given-names>
            </name>
            <name>
              <surname>Bliss</surname>
              <given-names>TVP</given-names>
            </name>
          </person-group>
          <article-title>Plasticity in the human central nervous system</article-title>
          <source>Brain</source>
          <year>2006</year>
          <volume>129</volume>
          <fpage>1659</fpage>
          <lpage>1673</lpage>
          <pub-id pub-id-type="pmid">16672292</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0003">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dai</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Sokabe</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Neurosteroid estradiol rescues ischemia-induced deficit in the long-term potentiation of rat hippocampal CA1 neurons</article-title>
          <source>Neuropharmacology</source>
          <year>2007</year>
          <volume>52</volume>
          <fpage>1124</fpage>
          <lpage>1138</lpage>
          <pub-id pub-id-type="pmid">17258238</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0004">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ito</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Im</surname>
              <given-names>WB</given-names>
            </name>
            <name>
              <surname>Takagi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Takahashi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Tsuzuki</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Liou</surname>
              <given-names>SY</given-names>
            </name>
            <name>
              <surname>Kunihara</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>U-92032, a T-type Ca<sup>2+</sup> channel blocker and antioxidant, reduces neuronal ischemic injuries</article-title>
          <source>Eur J Pharmacol</source>
          <year>1994</year>
          <volume>257</volume>
          <fpage>203</fpage>
          <lpage>210</lpage>
          <pub-id pub-id-type="pmid">8088342</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0005">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fisher</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>New approaches to neuroprotective drug development</article-title>
          <source>Stroke</source>
          <year>2011</year>
          <volume>42</volume>
          <issue>[suppl 1]</issue>
          <fpage>S24</fpage>
          <lpage>S27</lpage>
          <pub-id pub-id-type="pmid">21164111</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0006">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hor&#xE1;kov&#xE1;</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>&#x160;tolc</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Antioxidant and pharmacodynamic effect of pyridoindole stobadine</article-title>
          <source>Gen Pharmacol</source>
          <year>1998</year>
          <volume>30</volume>
          <fpage>627</fpage>
          <lpage>638</lpage>
          <pub-id pub-id-type="pmid">9559311</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0007">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>G&#xE1;sp&#xE1;rov&#xE1;</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Jariabka</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>&#x160;tolc</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Effect of transient ischemia on long-term potentiation of synaptic transmission in rat hippocampal slices</article-title>
          <source>Neuro Endocrinol Lett</source>
          <year>2008</year>
          <volume>29</volume>
          <fpage>702</fpage>
          <lpage>705</lpage>
          <pub-id pub-id-type="pmid">18987602</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0008">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>G&#xE1;sp&#xE1;rov&#xE1;</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Janega</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Bab&#xE1;l</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>&#x160;nirc</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>&#x160;tolc</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Mach</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ujh&#xE1;zy</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Effect of the new pyridoindole antioxidant SMe1EC2 on functional deficits and oedema formation in rat hippocampus exposed to ischaemia <italic>in vitro</italic>
</article-title>
          <source>Neuro Endocrinol Lett</source>
          <year>2009</year>
          <volume>30</volume>
          <fpage>574</fpage>
          <lpage>581</lpage>
          <pub-id pub-id-type="pmid">20035262</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0009">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>G&#xE1;sp&#xE1;rov&#xE1;</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Ondreji&#x10D;kov&#xE1;</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Gajdo&#x161;&#xED;kov&#xE1;</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Gajdo&#x161;&#xED;k</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>&#x160;nirc</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>&#x160;tolc</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Oxidative stress induced by the Fe<sup>2+</sup>/ascorbic acid system or model ischemia <italic>in vitro</italic>: Effect of carvedilol and pyridoindole antioxidant SMe1EC2 in young and adult rat brain tissue</article-title>
          <source>Interdiscip Toxicol</source>
          <year>2010a</year>
          <volume>3</volume>
          <fpage>122</fpage>
          <lpage>126</lpage>
        </element-citation>
      </ref>
      <ref id="CIT0010">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>G&#xE1;sp&#xE1;rov&#xE1;</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>&#x160;nirc</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>&#x160;tolc</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Dubovick&#xFD;</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Mach</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ujh&#xE1;zy</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Maternal treatment of rats with the new pyridoindole antioxidant during pregnancy and lactation resulting in improved offspring hippocampal resistance to ischemia <italic>in vitro</italic>
</article-title>
          <source>Neuro Endocrinol Lett</source>
          <year>2010b</year>
          <volume>31</volume>
          <fpage>348</fpage>
          <lpage>352</lpage>
        </element-citation>
      </ref>
      <ref id="CIT0011">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>G&#xE1;sp&#xE1;rov&#xE1;-Kvalt&#xED;nov&#xE1;</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>&#x160;tolc</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Effect of antioxidants and NMDA antagonists on the density of NMDA binding sites in rat hippocampal slices exposed to hypoxia/reoxygenation</article-title>
          <source>Methods Find Exp Clin Pharmacol</source>
          <year>2003</year>
          <volume>25</volume>
          <fpage>17</fpage>
          <lpage>25</lpage>
          <pub-id pub-id-type="pmid">12690702</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0012">
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Gemma</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Vila</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Bachstetter</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Bickford</surname>
              <given-names>PC</given-names>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Riddle</surname>
              <given-names>DR</given-names>
            </name>
          </person-group>
          <article-title>Oxidative stress and the aging brain: from theory to prevention</article-title>
          <source>Brain aging: Models, Methods, and Mechanisms</source>
          <year>2007</year>
          <publisher-loc>Boca Raton (FL)</publisher-loc>
          <publisher-name>CRC Press</publisher-name>
          <comment>Chapter 15</comment>
        </element-citation>
      </ref>
      <ref id="CIT0013">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Joseph</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Shukitt-Hale</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Denisova</surname>
              <given-names>NA</given-names>
            </name>
            <name>
              <surname>Bielinski</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Martin</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>McEwen</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Bickford</surname>
              <given-names>PC</given-names>
            </name>
          </person-group>
          <article-title>Reversals of age-related declines in neuronal signal transduction, cognitive, and motor behavioral deficits with blueberry, spinach, or strawberry dietary supplementation</article-title>
          <source>J Neurosci</source>
          <year>1999</year>
          <volume>19</volume>
          <fpage>8114</fpage>
          <lpage>8121</lpage>
          <pub-id pub-id-type="pmid">10479711</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0014">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Joseph</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Shukitt-Hale</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Denisova</surname>
              <given-names>NA</given-names>
            </name>
            <name>
              <surname>Prior</surname>
              <given-names>RL</given-names>
            </name>
            <name>
              <surname>Cao</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Martin</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Taglialatela</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Bickford</surname>
              <given-names>PC</given-names>
            </name>
          </person-group>
          <article-title>Long-term dietary strawberry, spinach, or vitamin E supplementation retards the onset of age-related neuronal signal-transduction and cognitive behavioral deficits</article-title>
          <source>J Neurosci</source>
          <year>1998</year>
          <volume>18</volume>
          <fpage>8047</fpage>
          <lpage>8055</lpage>
          <pub-id pub-id-type="pmid">9742171</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0015">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Keller</surname>
              <given-names>JN</given-names>
            </name>
            <name>
              <surname>Schmitt</surname>
              <given-names>FA</given-names>
            </name>
            <name>
              <surname>Scheff</surname>
              <given-names>SW</given-names>
            </name>
            <name>
              <surname>Ding</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Butterfield</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Markesbery</surname>
              <given-names>WR</given-names>
            </name>
          </person-group>
          <article-title>Evidence of increased oxidative damage in subjects with mild cognitive impairment</article-title>
          <source>Neurology</source>
          <year>2005</year>
          <volume>64</volume>
          <fpage>1152</fpage>
          <lpage>1156</lpage>
          <pub-id pub-id-type="pmid">15824339</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0016">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kvalt&#xED;nov&#xE1;</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>&#x160;tolc</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>NMDA binding sites in rat hippocampus under oxidative stress: Effect of antioxidants and NMDA antagonists</article-title>
          <source>Ann N Y Acad Sci</source>
          <year>1997</year>
          <volume>812</volume>
          <fpage>240</fpage>
          <lpage>242</lpage>
        </element-citation>
      </ref>
      <ref id="CIT0017">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Maalouf</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Rho</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
          <article-title>Oxidative impairment of hippocampal long-term potentiation involves activation of protein Phosphatase 2A and is prevented by ketone bodies</article-title>
          <source>J Neurosci Res</source>
          <year>2008</year>
          <volume>86</volume>
          <fpage>3322</fpage>
          <lpage>3330</lpage>
          <pub-id pub-id-type="pmid">18646208</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0018">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mariani</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Polidori</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Cherubini</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Mecocci</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Oxidative stress in brain aging, neurodegenerative and vascular diseases: an overview</article-title>
          <source>J Chromatogr B Analyt Technol Biomed Life Sci</source>
          <year>2005</year>
          <volume>827</volume>
          <fpage>65</fpage>
          <lpage>75</lpage>
        </element-citation>
      </ref>
      <ref id="CIT0019">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Miyazaki</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Katayama</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Lyeth</surname>
              <given-names>BG</given-names>
            </name>
            <name>
              <surname>Jenkins</surname>
              <given-names>LW</given-names>
            </name>
            <name>
              <surname>DeWitt</surname>
              <given-names>DS</given-names>
            </name>
            <name>
              <surname>Goldberg</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Newlon</surname>
              <given-names>PG</given-names>
            </name>
            <name>
              <surname>Hayes</surname>
              <given-names>RL</given-names>
            </name>
          </person-group>
          <article-title>Enduring suppression of hippocampal long-term potentiation following traumatic brain injury in rat</article-title>
          <source>Brain Res</source>
          <year>1992</year>
          <volume>585</volume>
          <fpage>335</fpage>
          <lpage>339</lpage>
          <pub-id pub-id-type="pmid">1511317</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0020">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Moreira</surname>
              <given-names>PI</given-names>
            </name>
            <name>
              <surname>Honda</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Zhu</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Nunomura</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Casadesus</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Perry</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Brain and brawn: parallels in oxidative strength</article-title>
          <source>Neurology</source>
          <year>2006</year>
          <volume>66</volume>
          <fpage>S97</fpage>
          <lpage>101</lpage>
          <pub-id pub-id-type="pmid">16432155</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0021">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Murray</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Lynch</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>Dietary supplementation with vitamin E reverses the age-related deficits in long-term potentiation in dentate gyrus</article-title>
          <source>J Biol Chem</source>
          <year>1998</year>
          <volume>273</volume>
          <fpage>12161</fpage>
          <pub-id pub-id-type="pmid">9575163</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0022">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Reeves</surname>
              <given-names>TM</given-names>
            </name>
            <name>
              <surname>Lyeth</surname>
              <given-names>BG</given-names>
            </name>
            <name>
              <surname>Povlishock</surname>
              <given-names>JT</given-names>
            </name>
          </person-group>
          <article-title>Long-term potentiation deficits and excitability changes following traumatic brain injury</article-title>
          <source>Exp Brain Res</source>
          <year>1995</year>
          <volume>106</volume>
          <fpage>248</fpage>
          <lpage>256</lpage>
          <pub-id pub-id-type="pmid">8566189</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0023">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sanders</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Sick</surname>
              <given-names>TJ</given-names>
            </name>
            <name>
              <surname>Perez-Pinzon</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Dietrich</surname>
              <given-names>WD</given-names>
            </name>
            <name>
              <surname>Green</surname>
              <given-names>EJ</given-names>
            </name>
          </person-group>
          <article-title>Chronic failure in the maintenance of long-term potentiation following fluid percussion injury in the rat</article-title>
          <source>Brain Res</source>
          <year>2000</year>
          <volume>861</volume>
          <fpage>69</fpage>
          <lpage>76</lpage>
          <pub-id pub-id-type="pmid">10751566</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0024">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schwarzbach</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Bonislawski</surname>
              <given-names>DP</given-names>
            </name>
            <name>
              <surname>Xiong</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Cohen</surname>
              <given-names>AS</given-names>
            </name>
          </person-group>
          <article-title>Mechanisms underlying the inability to induce area CA1 LTP in the mouse after traumatic brain injury</article-title>
          <source>Hippocampus</source>
          <year>2006</year>
          <volume>16</volume>
          <fpage>541</fpage>
          <lpage>550</lpage>
          <pub-id pub-id-type="pmid">16634077</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0025">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sick</surname>
              <given-names>TJ</given-names>
            </name>
            <name>
              <surname>Perez-Pinzon</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Feng</surname>
              <given-names>ZZ</given-names>
            </name>
          </person-group>
          <article-title>Impaired expression of long-term potentiation in hippocampal slices 4 and 48 h following mild fluid-percussion brain injury in vivo</article-title>
          <source>Brain Res</source>
          <year>1998</year>
          <volume>785</volume>
          <fpage>287</fpage>
          <lpage>292</lpage>
          <pub-id pub-id-type="pmid">9518654</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0026">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sopala</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Frankiewicz</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Parsons</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Danysz</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <article-title>Middle cerebral artery occlusion produces secondary, remote impairment in hippocampal plasticity of rats involvement of N-methyl-D-aspartate receptors?</article-title>
          <source>Neurosci Lett</source>
          <year>2000</year>
          <volume>281</volume>
          <fpage>143</fpage>
          <lpage>146</lpage>
          <pub-id pub-id-type="pmid">10704763</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0027">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>&#x160;tolc</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>&#x160;nirc</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>M&#xE1;jekov&#xE1;</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>G&#xE1;sp&#xE1;rov&#xE1;</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Gajdo&#x161;&#xED;kov&#xE1;</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>&#x160;tvrtina</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Development of the new group of indole-derived neuroprotective drugs affecting oxidative stress</article-title>
          <source>Cell Mol Neurobiol.</source>
          <year>2006</year>
          <volume>26</volume>
          <fpage>1493</fpage>
          <lpage>1502</lpage>
        </element-citation>
      </ref>
      <ref id="CIT0028">
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>&#x160;tolc</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>&#x160;nirc</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Gajdo&#x161;&#xED;kov&#xE1;</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Gajdo&#x161;&#xED;k</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>G&#xE1;sp&#xE1;rov&#xE1;</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Ondreji&#x10D;kov&#xE1;</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Sotn&#xED;kov&#xE1;</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Viola</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Rapta</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Jariabka</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Synekov&#xE1;</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Vajdov&#xE1;</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Zacharov&#xE1;</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Nem&#x10D;ek</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Krchn&#xE1;rov&#xE1;</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Bauer</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>New pyridoindoles with antioxidant and neuroprotective actions</article-title>
          <source>Trends in pharmacological research</source>
          <year>2008</year>
          <publisher-loc>Bratislava, Slovakia</publisher-loc>
          <publisher-name>Institute of Experimental Pharmacology</publisher-name>
          <fpage>118</fpage>
          <lpage>136</lpage>
        </element-citation>
      </ref>
      <ref id="CIT0029">
        <element-citation publication-type="confproc">
          <person-group person-group-type="author">
            <name>
              <surname>&#x160;tolc</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Pova&#x17E;anec</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Bauer</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>M&#xE1;jekov&#xE1;</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wilcox</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>&#x160;nirc</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Ra&#x10D;kov&#xE1;</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Sotn&#xED;kov&#xE1;</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>&#x160;tefek</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>G&#xE1;sp&#xE1;rov&#xE1;</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Gajdo&#x161;&#xED;kov&#xE1;</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Mih&#xE1;lov&#xE1;</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Alfoldi</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Pyridoindole derivatives with antioxidant properties: their synthesis and use in therapeutic practice (in Slovak) Slovak Patent No. 287506</article-title>
          <year>2010</year>
        </element-citation>
      </ref>
      <ref id="CIT0030">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tariq</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ai</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Sabri</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Jeon</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Shang</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Macdonald</surname>
              <given-names>RL</given-names>
            </name>
          </person-group>
          <article-title>Loss of long-term potentiation in the hippocampus after experimental subarachnoid hemorrhage in rats</article-title>
          <source>Neuroscience</source>
          <year>2010</year>
          <volume>165</volume>
          <fpage>418</fpage>
          <lpage>426</lpage>
          <pub-id pub-id-type="pmid">19854243</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0031">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vel&#xED;sek</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Extracellular acidosis and high level of carbon dioxide suppress synaptic transmission and prevent the induction of long-term potentiation in the CA1 region of rat hippocampal slices</article-title>
          <source>Hippocampus</source>
          <year>1998</year>
          <volume>8</volume>
          <fpage>24</fpage>
          <lpage>32</lpage>
          <pub-id pub-id-type="pmid">9519884</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0032">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yang</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Jiang</surname>
              <given-names>LN</given-names>
            </name>
            <name>
              <surname>Yuan</surname>
              <given-names>ZL</given-names>
            </name>
            <name>
              <surname>Zheng</surname>
              <given-names>YF</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Ji</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Shen</surname>
              <given-names>ZQ</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>XW</given-names>
            </name>
            <name>
              <surname>Ma</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Xi</surname>
              <given-names>ZG</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>JW</given-names>
            </name>
          </person-group>
          <article-title>Impacts of passive smoking on learning and memory ability of mouse offspring and intervention by antioxidants</article-title>
          <source>Biomed Environ Sci</source>
          <year>2008</year>
          <volume>21</volume>
          <fpage>144</fpage>
          <lpage>149</lpage>
          <pub-id pub-id-type="pmid">18548854</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0033">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>HL</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>XT</given-names>
            </name>
            <name>
              <surname>Yin</surname>
              <given-names>ST</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Tang</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>CY</given-names>
            </name>
            <name>
              <surname>Ruan</surname>
              <given-names>DY</given-names>
            </name>
          </person-group>
          <article-title>Opposite effects of alpha-lipoic acid on antioxidation and long-term potentiation in control and chronically lead-exposed rats</article-title>
          <source>Naunyn Schmied Arch Pharmacol</source>
          <year>2008</year>
          <volume>378</volume>
          <fpage>303</fpage>
          <lpage>310</lpage>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
